H Lundbeck A/S Stock

H Lundbeck A/S P/S 2024

H Lundbeck A/S P/S

1.68

Ticker

LUN.CO

ISIN

DK0010287234

WKN

922351

As of Dec 20, 2024, H Lundbeck A/S's P/S ratio stood at 1.68, a 0% change from the 0 P/S ratio recorded in the previous year.

The H Lundbeck A/S P/S history

H Lundbeck A/S Aktienanalyse

What does H Lundbeck A/S do?

H Lundbeck A/S is a Danish company that was founded in 1915 by Hans Lundbeck. Since its inception, the company has focused on researching and developing medications that improve the lives of people with neuropsychiatric disorders. Lundbeck's business model is based on a clear strategy and a strong focus on the research and development of pharmaceuticals. The company has four main therapy areas: depression, anxiety disorders, Alzheimer's, and Parkinson's. Lundbeck products are sold in over 100 countries worldwide and are known for their effectiveness and high quality. Over the years, Lundbeck has also focused on developing innovative treatment methods, including research on new drugs and therapies based on neurotransmitters such as serotonin, dopamine, and norepinephrine. With the acquisition of Alder BioPharmaceuticals in 2019, Lundbeck also expanded its portfolio in the field of migraine therapy. Some of Lundbeck's most well-known products include Lexapro, Cipralex, Selincro, Abilify Maintena, and Brintellix. These medications are used in the treatment of depression, anxiety disorders, alcoholism, bipolar disorders, and migraines. In addition to selling medications, Lundbeck also provides training and support for healthcare professionals and patients. Lundbeck is also distinguished by its commitment to social engagement and works closely with nonprofit organizations to raise awareness of neuropsychiatric disorders. The company has also launched various programs to improve access to medical care in particularly affected regions. In 2020, Lundbeck exceeded 18,000 employees worldwide and had a revenue of 16.6 billion Danish kroner. Lundbeck is listed on NASDAQ OMX Copenhagen and is controlled by the Lundbeck Foundation, which holds over 70% of the company's ownership. In summary, Lundbeck is a leading company in the field of neuropsychiatric medicine and is dedicated to improving the lives of people with these serious disorders. The company has made a name for itself through its successful research and development of therapies and medications, as well as its strong focus on social engagement and corporate social responsibility. H Lundbeck A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding H Lundbeck A/S's P/S Ratio

H Lundbeck A/S's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing H Lundbeck A/S's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating H Lundbeck A/S's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in H Lundbeck A/S’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about H Lundbeck A/S stock

What is the price-to-earnings ratio of H Lundbeck A/S?

The price-earnings ratio of H Lundbeck A/S is currently 1.68.

How has the price-earnings ratio of H Lundbeck A/S changed compared to last year?

The price-to-earnings ratio of H Lundbeck A/S has increased by 0% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of H Lundbeck A/S high compared to other companies?

Yes, the price-to-earnings ratio of H Lundbeck A/S is high compared to other companies.

How does an increase in the price-earnings ratio of H Lundbeck A/S affect the company?

An increase in the price-earnings ratio of H Lundbeck A/S would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of H Lundbeck A/S affect the company?

A decrease in the price-earnings ratio of H Lundbeck A/S would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of H Lundbeck A/S?

Some factors that influence the price-earnings ratio of H Lundbeck A/S are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does H Lundbeck A/S pay?

Over the past 12 months, H Lundbeck A/S paid a dividend of 2.5 DKK . This corresponds to a dividend yield of about 1.45 %. For the coming 12 months, H Lundbeck A/S is expected to pay a dividend of 15.45 DKK.

What is the dividend yield of H Lundbeck A/S?

The current dividend yield of H Lundbeck A/S is 1.45 %.

When does H Lundbeck A/S pay dividends?

H Lundbeck A/S pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of H Lundbeck A/S?

H Lundbeck A/S paid dividends every year for the past 10 years.

What is the dividend of H Lundbeck A/S?

For the upcoming 12 months, dividends amounting to 15.45 DKK are expected. This corresponds to a dividend yield of 8.94 %.

In which sector is H Lundbeck A/S located?

H Lundbeck A/S is assigned to the 'Health' sector.

Wann musste ich die Aktien von H Lundbeck A/S kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of H Lundbeck A/S from 3/28/2022 amounting to 2 DKK, you needed to have the stock in your portfolio before the ex-date on 3/24/2022.

When did H Lundbeck A/S pay the last dividend?

The last dividend was paid out on 3/28/2022.

What was the dividend of H Lundbeck A/S in the year 2023?

In the year 2023, H Lundbeck A/S distributed 2 DKK as dividends.

In which currency does H Lundbeck A/S pay out the dividend?

The dividends of H Lundbeck A/S are distributed in DKK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The H Lundbeck A/S stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von H Lundbeck A/S

Our stock analysis for H Lundbeck A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of H Lundbeck A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.